Overview
Ni Tang practices in Chongqing, China. Ms. Tang is rated as a Distinguished expert by MediFind in the treatment of PEPCK 1 Deficiency. Her top areas of expertise are PEPCK 1 Deficiency, Liver Cancer, Hepatitis, and Hepatitis B.
Her clinical research consists of co-authoring 103 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 7 articles in the study of PEPCK 1 Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- PEPCK 1 DeficiencyMs. Tang isDistinguished. Learn about PEPCK 1 Deficiency.
- Advanced
- HepatitisMs. Tang isAdvanced. Learn about Hepatitis.
- Hepatitis BMs. Tang isAdvanced. Learn about Hepatitis B.
- Liver CancerMs. Tang isAdvanced. Learn about Liver Cancer.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- CirrhosisMs. Tang isExperienced. Learn about Cirrhosis.
- COVID-19Ms. Tang isExperienced. Learn about COVID-19.
- Hepatitis CMs. Tang isExperienced. Learn about Hepatitis C.